Cargando…
Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649454/ http://dx.doi.org/10.1186/2051-1426-3-S2-P200 |
| _version_ | 1782401361498865664 |
|---|---|
| author | Tarakanovskaya, Marina G Chinburen, Jigjidsuren Purevsuren, Genden Munkhzaya, Chogsom Batchuluun, Purev Bat-Ireedui, Purev Dandii, Dorjiin Oyungerel, Dandii Kutsyna, Galyna A Bain, Allen I Jirathitikal, Vichai Bourinbaiar, Aldar S |
| author_facet | Tarakanovskaya, Marina G Chinburen, Jigjidsuren Purevsuren, Genden Munkhzaya, Chogsom Batchuluun, Purev Bat-Ireedui, Purev Dandii, Dorjiin Oyungerel, Dandii Kutsyna, Galyna A Bain, Allen I Jirathitikal, Vichai Bourinbaiar, Aldar S |
| author_sort | Tarakanovskaya, Marina G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649454 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46494542015-11-24 Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC Tarakanovskaya, Marina G Chinburen, Jigjidsuren Purevsuren, Genden Munkhzaya, Chogsom Batchuluun, Purev Bat-Ireedui, Purev Dandii, Dorjiin Oyungerel, Dandii Kutsyna, Galyna A Bain, Allen I Jirathitikal, Vichai Bourinbaiar, Aldar S J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649454/ http://dx.doi.org/10.1186/2051-1426-3-S2-P200 Text en Copyright © 2015 Tarakanovskaya et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Tarakanovskaya, Marina G Chinburen, Jigjidsuren Purevsuren, Genden Munkhzaya, Chogsom Batchuluun, Purev Bat-Ireedui, Purev Dandii, Dorjiin Oyungerel, Dandii Kutsyna, Galyna A Bain, Allen I Jirathitikal, Vichai Bourinbaiar, Aldar S Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC |
| title | Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC |
| title_full | Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC |
| title_fullStr | Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC |
| title_full_unstemmed | Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC |
| title_short | Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC |
| title_sort | immunotherapy of liver cancer with hepcortespenlisimut-l: open-label phase ii clinical study in patients with advanced hcc |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649454/ http://dx.doi.org/10.1186/2051-1426-3-S2-P200 |
| work_keys_str_mv | AT tarakanovskayamarinag immunotherapyoflivercancerwithhepcortespenlisimutlopenlabelphaseiiclinicalstudyinpatientswithadvancedhcc AT chinburenjigjidsuren immunotherapyoflivercancerwithhepcortespenlisimutlopenlabelphaseiiclinicalstudyinpatientswithadvancedhcc AT purevsurengenden immunotherapyoflivercancerwithhepcortespenlisimutlopenlabelphaseiiclinicalstudyinpatientswithadvancedhcc AT munkhzayachogsom immunotherapyoflivercancerwithhepcortespenlisimutlopenlabelphaseiiclinicalstudyinpatientswithadvancedhcc AT batchuluunpurev immunotherapyoflivercancerwithhepcortespenlisimutlopenlabelphaseiiclinicalstudyinpatientswithadvancedhcc AT batireeduipurev immunotherapyoflivercancerwithhepcortespenlisimutlopenlabelphaseiiclinicalstudyinpatientswithadvancedhcc AT dandiidorjiin immunotherapyoflivercancerwithhepcortespenlisimutlopenlabelphaseiiclinicalstudyinpatientswithadvancedhcc AT oyungereldandii immunotherapyoflivercancerwithhepcortespenlisimutlopenlabelphaseiiclinicalstudyinpatientswithadvancedhcc AT kutsynagalynaa immunotherapyoflivercancerwithhepcortespenlisimutlopenlabelphaseiiclinicalstudyinpatientswithadvancedhcc AT bainalleni immunotherapyoflivercancerwithhepcortespenlisimutlopenlabelphaseiiclinicalstudyinpatientswithadvancedhcc AT jirathitikalvichai immunotherapyoflivercancerwithhepcortespenlisimutlopenlabelphaseiiclinicalstudyinpatientswithadvancedhcc AT bourinbaiaraldars immunotherapyoflivercancerwithhepcortespenlisimutlopenlabelphaseiiclinicalstudyinpatientswithadvancedhcc |